Open | $173.740 |
Close | $170.690 |
Volume / Avg. | 4.955M / 2.423M |
Day Range | 170.410 - 174.280 |
52 Wk Range | 151.030 - 201.920 |
Market Cap | $77.942B |
P/E Ratio | 34.037 |
Dividend Yield | 1.000% |
Exchange | NYSE |
RSI | 27 |
Short Interest | % |
Days to Cover | 1.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), CymaBay Therapeutics (NASDAQ:CBAY) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Piper Sandler on Tuesday, February 20, 2024. The analyst firm set a price target for 220.00 expecting ZTS to rise to within 12 months (a possible 29.24% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $170.228 last updated March 18, 2024 at 6:17 PM EDT.
The next Zoetis (ZTS) dividend date is projected to be Thursday, April 18, 2024.
Zoetis’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.